| Title |
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
|
|---|---|
| Published in |
Drugs & Aging, May 2019
|
| DOI | 10.1007/s40266-019-00667-8 |
| Pubmed ID | |
| Authors |
Germain Honvo, Raveendhara R. Bannuru, Olivier Bruyère, Francois Rannou, Gabriel Herrero-Beaumont, Daniel Uebelhart, Cyrus Cooper, Nigel Arden, Philip G. Conaghan, Jean-Yves Reginster, Thierry Thomas, Tim McAlindon |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Belgium | 1 | 50% |
| France | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 68 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 21% |
| Student > Doctoral Student | 8 | 12% |
| Researcher | 5 | 7% |
| Student > Bachelor | 4 | 6% |
| Other | 3 | 4% |
| Other | 8 | 12% |
| Unknown | 26 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 25% |
| Nursing and Health Professions | 9 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 4 | 6% |
| Unknown | 31 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#15,572,469
of 23,146,350 outputs
Outputs from Drugs & Aging
#980
of 1,217 outputs
Outputs of similar age
#217,214
of 350,863 outputs
Outputs of similar age from Drugs & Aging
#26
of 34 outputs
Altmetric has tracked 23,146,350 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,217 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,863 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.